BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19485423)

  • 21. Method development for protein profiling in biological tissues by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
    Djidja MC; Carolan V; Loadman PM; Clench MR
    Rapid Commun Mass Spectrom; 2008 May; 22(10):1615-8. PubMed ID: 18433085
    [No Abstract]   [Full Text] [Related]  

  • 22. Achieving in-depth proteomics profiling by mass spectrometry.
    Ahn NG; Shabb JB; Old WM; Resing KA
    ACS Chem Biol; 2007 Jan; 2(1):39-52. PubMed ID: 17243782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of immunohistochemistry and laser ablation ICP mass spectrometry for imaging of cancer biomarkers.
    Seuma J; Bunch J; Cox A; McLeod C; Bell J; Murray C
    Proteomics; 2008 Sep; 8(18):3775-84. PubMed ID: 18712769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis.
    Sun MZ; Liu S; Tang J; Wang Z; Gong X; Sun C; Greenaway F
    Proteomics; 2009 Jun; 9(12):3285-302. PubMed ID: 19562801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic analysis reveals differences in protein expression in spheroid versus monolayer cultures of low-passage colon carcinoma cells.
    Gaedtke L; Thoenes L; Culmsee C; Mayer B; Wagner E
    J Proteome Res; 2007 Nov; 6(11):4111-8. PubMed ID: 17918984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma.
    Zhu H; Pei HP; Zeng S; Chen J; Shen LF; Zhong MZ; Yao RJ; Shen H
    J Proteome Res; 2009 Aug; 8(8):3969-76. PubMed ID: 19507834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells.
    Roesli C; Borgia B; Schliemann C; Gunthert M; Wunderli-Allenspach H; Giavazzi R; Neri D
    Cancer Res; 2009 Jul; 69(13):5406-14. PubMed ID: 19491280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
    Liu DH; Zhang LM; Feng WY
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
    [No Abstract]   [Full Text] [Related]  

  • 29. Isolation, identification and quantification of differentially expressed proteins from cancerous and normal breast tissues.
    Othman MI; Majid MI; Singh M; Man CN; Lay-Harn G
    Ann Clin Biochem; 2008 May; 45(Pt 3):299-306. PubMed ID: 18482919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-Gel 18O labeling for improved identification of proteins from 2-DE Gel spots in comparative proteomic experiments.
    Broedel O; Krause E; Stephanowitz H; Schuemann M; Eravci M; Weist S; Brunkau C; Wittke J; Eravci S; Baumgartner A
    J Proteome Res; 2009 Jul; 8(7):3771-7. PubMed ID: 19425618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry.
    Imai K; Ichibangase T; Saitoh R; Hoshikawa Y
    Biomed Chromatogr; 2008 Nov; 22(11):1304-14. PubMed ID: 18821527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A proteomic approach for the identification of vascular markers of liver metastasis.
    Borgia B; Roesli C; Fugmann T; Schliemann C; Cesca M; Neri D; Giavazzi R
    Cancer Res; 2010 Jan; 70(1):309-18. PubMed ID: 19996283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences.
    Becker JS; Jakubowski N
    Chem Soc Rev; 2009 Jul; 38(7):1969-83. PubMed ID: 19551177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SELDI-TOF serum proteomics and breast cancer: which perspective?
    Garrisi VM; Abbate I; Quaranta M; Mangia A; Tommasi S; Paradiso A
    Expert Rev Proteomics; 2008 Dec; 5(6):779-85. PubMed ID: 19086858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection.
    Hong YJ; Wang XD; Shen D; Zeng S
    Acta Pharmacol Sin; 2008 Oct; 29(10):1240-6. PubMed ID: 18817630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing rice embryo proteomics reveals essential role for embryonic proteins in regulation of seed germination.
    Kim ST; Wang Y; Kang SY; Kim SG; Rakwal R; Kim YC; Kang KY
    J Proteome Res; 2009 Jul; 8(7):3598-605. PubMed ID: 19472976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unbiased examination of changes in plasma membrane proteins in drug resistant cancer cells.
    Rahbar AM; Fenselau C
    J Proteome Res; 2005; 4(6):2148-53. PubMed ID: 16335961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features.
    Ishihara A; Tsuda H; Kitagawa K; Yoneda M; Shiraishi T
    Breast Cancer; 2009; 16(3):179-85. PubMed ID: 19466513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass spectrometry-based functional proteomics: from molecular machines to protein networks.
    Köcher T; Superti-Furga G
    Nat Methods; 2007 Oct; 4(10):807-15. PubMed ID: 17901870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Proteomic study of paclitaxel on human cervical carcinoma HCE1].
    Cao LQ; Lin QH; Li X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 33(6):512-7. PubMed ID: 18599999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.